After experimental validation, we hoped that the assessment of both SHMT2 and its co-expressed gene in kidney cancer will be helpful in predicting kidney cancer prognosis and providing a novelty therapeutic target for individual treatment of kidney cancer. Here, SHMT2 is linked to kidney cancer.